{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:37:57Z","timestamp":1792431477490,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ajog.2008.04.048","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T15:33:31Z","timestamp":1215444811000},"page":"351.e1-351.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Physiologic and psychologic symptoms associated with use of injectable contraception and 20 \u03bcg oral contraceptive pills"],"prefix":"10.1016","volume":"199","author":[{"given":"Abbey B.","family":"Berenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Odom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Radecki","family":"Breitkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbubur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2008.04.048_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0029-7844(96)00194-9","article-title":"Experiences of injectable contraceptive users in an urban setting","volume":"88","author":"Sangi-Haghpeykar","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1054-139X(98)00014-7","article-title":"Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents","volume":"23","author":"Polaneczky","year":"1998","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.ajog.2008.04.048_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(97)00160-1","article-title":"Depot medroxyprogesterone acetate pioneers","volume":"56","author":"Potter","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.contraception.2005.01.005","article-title":"Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women","volume":"72","author":"Aktun","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archpedi.153.10.1068","article-title":"Depot medroxyprogesterone acetate use in inner-city, minority adolescents: continuation rates and characteristics of long-term users","volume":"153","author":"Lim","year":"1999","journal-title":"Arch Ped Adolesc Med"},{"key":"10.1016\/j.ajog.2008.04.048_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1542\/peds.94.5.687","article-title":"A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2008.04.048_bib7","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2105\/AJPH.87.9.1532","article-title":"Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women","volume":"87","author":"Davidson","year":"1997","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajog.2008.04.048_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1083-3188(97)70039-1","article-title":"Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females","volume":"10","author":"Matson","year":"1997","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib9","first-page":"391","article-title":"Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception","volume":"41","author":"Nelson","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ajog.2008.04.048_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.5694\/j.1326-5377.1994.tb138344.x","article-title":"Depo-Provera use in an Australian metropolitan practice","volume":"160","author":"Fraser","year":"1994","journal-title":"Med J Aust"},{"key":"10.1016\/j.ajog.2008.04.048_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2006.03.022","article-title":"Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives","volume":"74","author":"Sabatini","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0002-9378(98)70290-X","article-title":"An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive","volume":"179","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0010-7824(01)00235-9","volume":"64","author":"Endrikat","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-7824(99)00097-9","article-title":"Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study","volume":"60","author":"Endrikat","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0010-7824(02)00414-6","article-title":"Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive","volume":"66","author":"Hendrix","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/2136195","article-title":"Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population","volume":"28","author":"Polaneczky","year":"1996","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.ajog.2008.04.048_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/1054-139X(95)00322-J","article-title":"Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant","volume":"19","author":"Harel","year":"1996","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.ajog.2008.04.048_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0010-7824(97)00157-1","article-title":"A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles","volume":"56","author":"Bannemerschult","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00044011-200626030-00004","article-title":"Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20 micrograms and drospirenone 3 mg","volume":"26","author":"Cibula","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ajog.2008.04.048_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0010-7824(00)00153-0","article-title":"Latin American experience with two low-dose oral contraceptives containing 30 micrograms ethinylestradiol\/75 micrograms gestodene and 20 micrograms ethinylestradiol\/150 micrograms desogestrel","volume":"62","author":"Bassol","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.fertnstert.2005.10.031","article-title":"Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes","volume":"85","author":"Rapkin","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.04.048_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 microgram and 35 microgram estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/ejc.7.4.238.243","article-title":"Improvement of quality of life in women using a low-dose desogestrel-containing contraceptive: results of an observational clinical evaluation","volume":"7","author":"Ernst","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2008.04.048_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2006.09.008","article-title":"Oral contraceptives: side effects and depression in adolescent girls","volume":"75","author":"O'Connell","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(99)00069-4","article-title":"Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence","volume":"60","author":"Redmond","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.contraception.2003.12.017","article-title":"Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 micrograms ethinylestradiol","volume":"69","author":"Winkler","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib28","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.ajog.2008.04.048_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0033-3182(71)71479-0","article-title":"A rating instrument for anxiety disorders","volume":"12","author":"Zung","year":"1971","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ajog.2008.04.048_bib30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J Pers Soc Psychol"},{"key":"10.1016\/j.ajog.2008.04.048_bib31","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1176\/ajp.143.11.1471","article-title":"Prevalence of clinically significant anxiety in a family practice setting","volume":"143","author":"Zung","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2008.04.048_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2007-993855","article-title":"Fatigue in pregnancy: a comparative study","volume":"16","author":"Behrenz","year":"1999","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2008.04.048_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.ajog.2008.04.048_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub3","article-title":"Combined oral contraceptive pills for treatment of acne (review)","author":"Arowojolu","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2008.04.048_bib35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMcp033487","article-title":"Clinical practice","volume":"352","author":"James","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.04.048_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib37","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajog.2008.04.048_bib38","first-page":"9S","article-title":"Acne treatment with a low-dose oral contraceptive","volume":"97","author":"Gilliam","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 micrograms of ethinyl estradiol and 100 micrograms of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.04.048_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 micrograms of ethinyl estradiol and 100 micrograms of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajog.2008.04.048_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2007.08.011","article-title":"Oral contraceptives and benign breast disease: an update of findings in a large cohort study","volume":"76","author":"Vessey","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2001-18637","article-title":"Noncontraceptive benefits and therapeutic uses of the oral contraceptive pill","volume":"19","author":"Dayal","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2008.04.048_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0010-7824(03)00136-7","article-title":"Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety","volume":"68","author":"Westhoff","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00737-005-0102-z","article-title":"Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model","volume":"9","author":"Kurshan","year":"2006","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajog.2008.04.048_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.ajog.2008.04.048_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib47","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.contraception.2007.05.085","article-title":"Attitudes towards long-acting reversible methods of contraception in general practice in the UK","volume":"76","author":"Wellings","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib50","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1471-0528.1993.tb14309.x","article-title":"Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol","volume":"9","author":"Akerlund","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0010-7824(97)00025-5","volume":"55","author":"Endrikat","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib52","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1016\/S0002-9378(99)70719-2","article-title":"Cycle control with oral contraceptives: a review of the literature","volume":"180","author":"Thorneycroft","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9378(96)70440-4","article-title":"Smoking and cycle control among oral contraceptive users","volume":"174","author":"Rosenberg","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib54","first-page":"728","article-title":"Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting","volume":"81","author":"Krettek","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.04.048_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(01)00181-0","article-title":"Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate","volume":"63","author":"Canto de Cetina","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2008.04.048_bib56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)39669-8","article-title":"Contraceptive use\u2014efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days","volume":"24","author":"Schwallie","year":"1973","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.04.048_bib57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/13625189609150670","article-title":"Attitudes to current oral contraceptive use and future developments: the women's perspective","volume":"1","author":"Fuchs","year":"1996","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2008.04.048_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.contraception.2007.06.008","article-title":"Contraceptive discontinuation attributed to method dissatisfaction in the United States","volume":"76","author":"Moreau","year":"2007","journal-title":"Contraception"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808005000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808005000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:27:20Z","timestamp":1757586440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937808005000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0002937808005000"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2008.04.048","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20 \u03bcg oral contraceptive pills","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2008.04.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}